Clinical Trial Update: Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC [Phase 2]

View source ↗

Summary

Phase II study in elderly patients with IIIB/IV non-small cell lung cancer evaluating gemcitabine with erlotinib (and related regimens); results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-24